B. Riley Begins Coverage on Mirion Technologies (NYSE:MIR)

B. Riley assumed coverage on shares of Mirion Technologies (NYSE:MIR) in a report published on Thursday, Marketbeat.com reports. The firm issued a buy rating and a $14.00 price objective on the stock.

Mirion Technologies Price Performance

Shares of MIR opened at $11.05 on Thursday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.55 and a current ratio of 2.18. The firm has a market cap of $2.57 billion, a PE ratio of -26.95 and a beta of 0.79. The firm’s 50 day moving average price is $10.41 and its 200 day moving average price is $10.60. Mirion Technologies has a twelve month low of $6.70 and a twelve month high of $11.78.

Mirion Technologies (NYSE:MIR) last released its quarterly earnings results on Thursday, August 1st. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.03. The business had revenue of $207.10 million for the quarter, compared to the consensus estimate of $210.77 million. Mirion Technologies had a negative net margin of 7.80% and a positive return on equity of 3.81%. Mirion Technologies’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.08 EPS.

Insider Activity

In related news, CEO Thomas D. Logan sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, July 24th. The stock was sold at an average price of $10.87, for a total value of $81,525.00. Following the completion of the sale, the chief executive officer now directly owns 1,544,017 shares in the company, valued at approximately $16,783,464.79. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, insider Emmanuelle Lee sold 5,000 shares of the firm’s stock in a transaction on Tuesday, September 24th. The shares were sold at an average price of $10.60, for a total value of $53,000.00. Following the transaction, the insider now directly owns 138,193 shares in the company, valued at approximately $1,464,845.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Thomas D. Logan sold 7,500 shares of the business’s stock in a transaction on Wednesday, July 24th. The stock was sold at an average price of $10.87, for a total transaction of $81,525.00. Following the transaction, the chief executive officer now directly owns 1,544,017 shares of the company’s stock, valued at approximately $16,783,464.79. The disclosure for this sale can be found here. In the last quarter, insiders have sold 54,639 shares of company stock valued at $568,947. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Mirion Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the business. Innealta Capital LLC bought a new stake in Mirion Technologies during the 2nd quarter valued at approximately $39,000. Central Pacific Bank Trust Division bought a new stake in shares of Mirion Technologies in the first quarter valued at approximately $85,000. Algert Global LLC acquired a new stake in shares of Mirion Technologies in the second quarter worth $189,000. Bayesian Capital Management LP bought a new position in Mirion Technologies during the first quarter worth $226,000. Finally, Lazard Asset Management LLC raised its stake in Mirion Technologies by 19.8% during the 1st quarter. Lazard Asset Management LLC now owns 22,751 shares of the company’s stock valued at $258,000 after purchasing an additional 3,753 shares during the last quarter. 78.51% of the stock is owned by institutional investors and hedge funds.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.